FDA panel recommends approval for copy of arthritis drug Remicade

A copy of a popular arthritis drug is one step closer to receiving regulatory approval, which could bring some financial relief to patients. Celltrion, a South Korean company, has developed a knockoff of Johnson & Johnson’s Remicade, which is used to treat autoimmune conditions such as rheumatoid arthritis, chronic inflammation of the digestive tract and plaque…

Save

Save

Comments are closed.